Findings on Optical Colonoscopy After Positive CT Colonography Exam

Section of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin 53792-5124, USA.
The American Journal of Gastroenterology (Impact Factor: 10.76). 06/2008; 103(8):2068-74. DOI: 10.1111/j.1572-0241.2008.01919.x
Source: PubMed


The aim of this study is to evaluate the findings on optical colonoscopy (OC) after a positive CT colonography (CTC) exam and characterize the type of polyps seen on OC but not reported by CTC.
Over an 18-month period a total of 159 asymptomatic adults had polyps seen on computed tomography colonography examination and subsequently underwent planned therapeutic optical colonoscopy. The colonoscopists were aware of the findings on CT colonography prior to further evaluation of the colon. Characteristics of polyps and adenomas seen on subsequent optical colonoscopy but not seen or reported on CT colonography were examined.
The adenoma miss rate for CT colonography overall was 18.9% (25/132) including 6.2% (4/65) for polyps >9 mm and 18.2% (8/44) for polyps 6-9 mm. Three of the adenomas >9 mm not seen on CTC were sessile, and two were found in patients with technically difficult CT colonography studies due to poor colonic distention. No adenomas with advanced pathology <6 mm were found on optical colonoscopy but not reported on CT colonography. False-positive CTC referral where no polyp was seen on colonoscopy was 5.0%.
CT colonography has adenoma miss rates similar to miss rates historically found with optical colonoscopy, with most missed adenomas being <10 mm and sessile in shape.

Download full-text


Available from: Deepak V Gopal, Apr 09, 2014
  • Source
    • "[1]. Unfortunately, even in subjects who adhere to these screening recommendations, approximately 20% of colorectal neoplasms escape detection by standard white-light colonoscopy [2] [3]. This is most problematic for small mucosal colorectal lesions and nonpolypoid (flat) or depressed lesions that lack an elevated growth component (approximately 15%), especially in the right part of the colon [4]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A significant proportion of colorectal adenomas, in particular those that lack an elevated growth component, continue to escape detection during endoscopic surveillance. Elevation of the activity of matrix metalloproteinases (MMPs), a large family of zinc endopeptidases, in adenomas serves as a biomarker of early tumorigenesis. The goal of this study was to assess the feasibility of using a newly developed near-infrared bioactivatable probe (MMPSense 680) that reports the activity of a broad array of MMP isoforms to detect early colorectal adenomas. Adenomatous polyposis coli (Apc)(+/Min-FCCC) mice that spontaneously develop multiple colorectal adenomas were injected with MMPSense 680, and the colons were imaged in an IVIS Spectrum system ex vivo. Image analyses were correlated with histopathologic findings for all regions of interest (ROIs). The biochemical basis of fluorescent signal was investigated by immunohistochemical staining of MMP-7 and -9. A strong correlation (Kendall = 0.80) was observed between a positive signal and the presence of pathologically confirmed colonic adenomas; 92.9% of the 350 ROIs evaluated were classified correctly. The correlation between two independent observers was 0.87. MMP-7 expression was localized to epithelial cells of adenomas and microadenomas, whereas staining of MMP-9 was found in infiltrating polymorphonuclear leukocytes within the adenomas. MMPSense 680 identifies colorectal adenomas, both polypoid and nonpolypoid, in Apc(+/Min-FCCC) mice with high specificity. Use of this fluorescent probe in combination with colonoscopy could aid in preventing colorectal neoplasias by providing new opportunities for early detection and therapeutic intervention.
    Preview · Article · Aug 2011 · Neoplasia (New York, N.Y.)

  • No preview · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Computed tomographic colonography (CTC) is less expensive, less time-consuming and better tolerated for patients than is optical colonoscopy. At present, CTC has a diagnostic performance similar to that of optical colonoscopy for detection of colorectal polyps. The American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology now list CTC as a viable colorectal cancer screening option in its new joint guideline. In addition, CTC can provide accurate preoperative staging and thus can be a useful tool for navigation surgery. Objective: In this review, the authors discuss the essential aspects of minimum-invasive early diagnosis of colorectal cancer based on CTC, including the current techniques for patient preparation, data acquisition, image display and interpretation, the CTC performance for screening, preoperative staging, and navigation surgery. Results/conclusion: Increased screening by CTC is expected to result in a decrease in the incidence of and mortality due to CRC. Increased preoperative staging and navigation surgery by use of CTC is expected to secure an accurate choice of the precise therapeutic plan and a safer performance of surgery. Together, a comprehensive program for screening, preoperative staging, and navigation surgery based on CTC will ultimately reduce the mortality due to CRC.
    Full-text · Article · Nov 2008 · Expert Opinion on Medical Diagnostics
Show more